Dr. Kumar Rishikesh is a highly experienced Medical Oncologist with more than 8 years of dedicated service in the field of oncology. Based in South Delhi, India, he combines extensive medical knowledge with a compassionate, patient-centered approach, ensuring that each individual receives personalized care tailored to their unique needs. His academic excellence is reflected in his impressive qualifications, including an MBBS, MD (Medicine), DNB in Medical Oncology, and a prestigious Fellowship in Medical Oncology & Hematology from the Princess Margaret Cancer Centre at the University of Toronto, Canada. Fluent in multiple languages including English, Hindi, Bengali, and Maithili, Dr. Rishikesh is uniquely equipped to communicate effectively with a diverse patient population, making him an excellent choice for international patients seeking world-class cancer care in India. He is a recognized member of esteemed global organizations such as the European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO), reflecting his commitment to staying at the forefront of cancer treatment advancements. Dr. Rishikesh's clinical expertise spans a wide range of oncological conditions, from common malignancies such as breast cancer and gastric cancer to rare and complex cancers. His research contributions in areas including molecular tumor boards, neoadjuvant chemotherapy response, and hematologic conditions further underscore his dedication to advancing cancer care.
- Medical Oncology
- Hematology & BMT
- Chemotherapy for Cancer
- Cancer Immunotherapy
- Targeted Therapy for Cancer
- Hormone Therapy for Breast Cancer
- Hormone Therapy for Prostate Cancer
- Hormonal Therapy for Gynaecologic Cancers
- CAR-T Cell Therapy
- Blood Cancer Treatment (Leukemia, Lymphoma, Myeloma)
- MBBS
- MD (Medicine)
- DNB (Medical Oncology)
- Fellowship in Medical Oncology & Hematology
- Indraprastha Apollo Hospital, Delhi
- Implementation of Multidisciplinary Molecular Tumor Board in GYCA
- High Prevalence of Anemia Among HIV-Infected Adults in India
- Correlation Between Neoadjuvant Chemotherapy and Pathological Response in Advanced Breast Cancer
- European Society for Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.